Harvard Bioscience (HBIO) Short-term Investments (2018 - 2024)
Harvard Bioscience (HBIO) reported Short-term Investments of $34000.0 for Q2 2024, up 120.0% quarter-over-quarter from -$170000.0 in Q4 2018.
Harvard Bioscience (HBIO) Short-term Investments (2018 - 2024) Analysis & Trends
Harvard Bioscience (HBIO) has 2 years of Short-term Investments data on file, last reported at $34000.0 in Q2 2024.
- Short-term Investments for Q2 2024 came in at $34000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $34000.0 (changed N/A YoY), and the FY2018 annual result was -$170000.0, changed N/A from the prior year.
- Short-term Investments rose to $34000.0 in Q2 2024 per HBIO's latest filing, from -$170000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $34000.0 in Q2 2024 and troughed at $34000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 34,000.00 |
| Dec 31, 2018 | -170,000.00 |